ACA

Avoro Capital Advisors Portfolio holdings

AUM $5.71B
1-Year Return 11.37%
This Quarter Return
+10.81%
1 Year Return
+11.37%
3 Year Return
+255.37%
5 Year Return
+558.9%
10 Year Return
+18,722.72%
AUM
$7.37B
AUM Growth
+$632M
Cap. Flow
+$320M
Cap. Flow %
4.34%
Top 10 Hldgs %
69.13%
Holding
45
New
6
Increased
11
Reduced
7
Closed
1

Top Buys

1
SRPT icon
Sarepta Therapeutics
SRPT
$112M
2
KRYS icon
Krystal Biotech
KRYS
$95.2M
3
MLTX icon
MoonLake Immunotherapeutics
MLTX
$88M
4
ROIV icon
Roivant Sciences
ROIV
$58.5M
5
ISEE
IVERIC bio, Inc. Common Stock
ISEE
$49.2M

Top Sells

1
DICE
DICE Therapeutics, Inc. Common Stock
DICE
$81.3M
2
MDGL icon
Madrigal Pharmaceuticals
MDGL
$35M
3
AMLX icon
Amylyx Pharmaceuticals
AMLX
$13.9M
4
NUVL icon
Nuvalent
NUVL
$12.2M
5
ARGX icon
argenx
ARGX
$9.35M

Sector Composition

1 Healthcare 99.54%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
RARE icon
26
Ultragenyx Pharmaceutical
RARE
$3.07B
$34.6M 0.47%
750,000
– –
MRNS
27
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$34.2M 0.46%
3,150,000
– –
KURA icon
28
Kura Oncology
KURA
$713M
$32.9M 0.45%
3,105,000
– –
GLUE icon
29
Monte Rosa Therapeutics
GLUE
$305M
$31.1M 0.42%
4,535,000
+210,000
+5% +$1.44M
RNA icon
30
Avidity Biosciences
RNA
$6.48B
$27.8M 0.38%
2,510,000
– –
DSGN icon
31
Design Therapeutics
DSGN
$367M
$22.1M 0.3%
3,500,000
– –
MRSN icon
32
Mersana Therapeutics
MRSN
$34M
$21M 0.28%
255,000
-47,000
-16% -$3.87M
WHWK
33
Whitehawk Therapeutics, Inc. Common Stock
WHWK
$85.8M
$19.5M 0.26%
2,849,402
– –
PMVP icon
34
PMV Pharmaceuticals
PMVP
$77.4M
$19.2M 0.26%
3,060,000
– –
VRCA icon
35
Verrica Pharmaceuticals
VRCA
$48.3M
$17M 0.23%
295,406
+30,406
+11% +$1.75M
ARWR icon
36
Arrowhead Research
ARWR
$4.02B
$12.7M 0.17%
+357,403
New +$12.7M
MCRB icon
37
Seres Therapeutics
MCRB
$169M
$12M 0.16%
125,000
+60,250
+93% +$5.77M
IMA
38
ImageneBio, Inc. Common Stock
IMA
$89M
$10.8M 0.15%
+136,667
New +$10.8M
FENC icon
39
Fennec Pharmaceuticals
FENC
$250M
$10.6M 0.14%
1,200,000
– –
TNGX icon
40
Tango Therapeutics
TNGX
$772M
$5.44M 0.07%
1,640,000
– –
IOBT icon
41
IO Biotech
IOBT
$128M
$4.03M 0.05%
2,055,883
– –
TRML icon
42
Tourmaline Bio
TRML
$687M
$1.52M 0.02%
+50,000
New +$1.52M
SYRE icon
43
Spyre Therapeutics
SYRE
$1.03B
$129K ﹤0.01%
+11,458
New +$129K
AMLX icon
44
Amylyx Pharmaceuticals
AMLX
$910M
– –
-473,100
Closed -$13.9M
XBI icon
45
SPDR S&P Biotech ETF
XBI
$5.39B
– –
0
– –
1
2